EA201890212A1 - Новое применение сульфата декстрана - Google Patents

Новое применение сульфата декстрана

Info

Publication number
EA201890212A1
EA201890212A1 EA201890212A EA201890212A EA201890212A1 EA 201890212 A1 EA201890212 A1 EA 201890212A1 EA 201890212 A EA201890212 A EA 201890212A EA 201890212 A EA201890212 A EA 201890212A EA 201890212 A1 EA201890212 A1 EA 201890212A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dextran sulfate
sulfate application
new dextran
new
application
Prior art date
Application number
EA201890212A
Other languages
English (en)
Other versions
EA034313B1 (ru
Inventor
Ларс Брюс
Адам Брюс
Андерс Ваас
Original Assignee
Тх Медик Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тх Медик Аб filed Critical Тх Медик Аб
Publication of EA201890212A1 publication Critical patent/EA201890212A1/ru
Publication of EA034313B1 publication Critical patent/EA034313B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Настоящие варианты осуществления относятся к применению сульфата декстрана, предназначенного для системного введения для лечения, ингибирования или предупреждения фиброза миокарда у субъекта.
EA201890212A 2015-07-30 2016-07-15 Применение сульфата декстрана EA034313B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1551050A SE539575C2 (en) 2015-07-30 2015-07-30 Dextran sulfate for use in treating, inhibiting or preventing cardiac fibrosis
PCT/SE2016/050720 WO2017018922A1 (en) 2015-07-30 2016-07-15 New use of dextran sulfate

Publications (2)

Publication Number Publication Date
EA201890212A1 true EA201890212A1 (ru) 2018-06-29
EA034313B1 EA034313B1 (ru) 2020-01-28

Family

ID=57884849

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201890212A EA034313B1 (ru) 2015-07-30 2016-07-15 Применение сульфата декстрана

Country Status (11)

Country Link
US (1) US10478451B2 (ru)
EP (1) EP3328395B1 (ru)
JP (1) JP6837679B2 (ru)
CN (2) CN107921055A (ru)
BR (1) BR112018001942A2 (ru)
DK (1) DK3328395T3 (ru)
EA (1) EA034313B1 (ru)
ES (1) ES2882115T3 (ru)
HK (1) HK1246640A1 (ru)
SE (1) SE539575C2 (ru)
WO (1) WO2017018922A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6817466B2 (ja) 2017-05-17 2021-01-20 ティーエックス メディック エービー 緑内障の治療
WO2018212708A1 (en) * 2017-05-17 2018-11-22 Tx Medic Ab Treatment of glaucoma
JP2020533281A (ja) * 2017-09-08 2020-11-19 ティーエックス メディック エービー デキストラン硫酸の新規使用
KR20200129114A (ko) * 2018-03-09 2020-11-17 카르메다 아베 생물학적 실체를 고정화하기 위한 방법에 대한 개선
SE543275C2 (en) * 2019-03-07 2020-11-10 Tx Medic Ab Treatment efficiency evaluation
SE544447C2 (en) * 2020-09-29 2022-05-31 Tx Medic Ab Treatment of fatty liver diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
AU1042597A (en) 1995-12-18 1997-07-14 Stichting Sanquin Bloedvoorziening Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
US20040224922A1 (en) 1999-08-26 2004-11-11 Malcolm King Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto
SE525461C3 (sv) * 2002-11-28 2005-03-23 Prophymed Ab Ny användning av dextransulfat
CA2685208C (en) 2007-04-24 2014-04-08 Novelmed Therapeutics, Inc. Methods and compositions of inhibiting complement and cellular activation with dextran sulfate
CN102973593A (zh) * 2012-11-26 2013-03-20 合肥博太医药生物技术发展有限公司 硫酸葡聚糖在制备治疗肝纤维化药物中的应用
WO2015190989A1 (en) * 2014-06-12 2015-12-17 Tx Medic Ab The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject

Also Published As

Publication number Publication date
EA034313B1 (ru) 2020-01-28
DK3328395T3 (da) 2021-08-09
CN114712385A (zh) 2022-07-08
US20180221403A1 (en) 2018-08-09
EP3328395B1 (en) 2021-06-09
EP3328395A4 (en) 2018-06-20
WO2017018922A1 (en) 2017-02-02
JP2018521086A (ja) 2018-08-02
US10478451B2 (en) 2019-11-19
SE1551050A1 (en) 2017-01-31
CN107921055A (zh) 2018-04-17
EP3328395A1 (en) 2018-06-06
ES2882115T3 (es) 2021-12-01
BR112018001942A2 (pt) 2018-09-18
SE539575C2 (en) 2017-10-17
JP6837679B2 (ja) 2021-03-03
HK1246640A1 (zh) 2018-09-14

Similar Documents

Publication Publication Date Title
EA201890212A1 (ru) Новое применение сульфата декстрана
MX2017004579A (es) Estructuras fibrosas solubles y metodos para fabricarlas.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
CL2015002860A1 (es) Antagonistas de la alfa-v-beta-6 integrina
MX2015009105A (es) Composiciones en solucion solida y su uso en inflamacion cronica.
TR201902516T4 (tr) Glukagon-glp-1-gıp üçlü agonist bileşikleri.
UA117008C2 (uk) IN VITRO ТРАНСКРИБОВАНА мРНК ТА КОМПОЗИЦІЯ, ЩО ЇЇ МІСТИТЬ, ДЛЯ ЗАСТОСУВАННЯ В ЛІКУВАННІ МУКОВІСЦИДОЗУ В ССАВЦЯ
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
BR112016006613A2 (pt) métodos para produção, estabilização e uso de blastosporos fúngicos
Marvier A call for ecumenical conservation.
DK3606926T3 (da) Heteroaromatiske forbindelser anvendelige i terapi
BR112018000217A2 (pt) sistemas de distribuição de nanopartículas aperfeiçoados
AR110404A1 (es) MÉTODOS PARA EL TRATAMIENTO DE ENFERMEDADES FIBRÓTICAS UTILIZANDO EL INTERFERÓN-l
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
TWD180565S (zh) 塗抹器
EA032472B9 (ru) Композиция для укладки волос
FR3026399B1 (fr) Grue, notamment grue-derrick
MX2015013151A (es) Métodos de tratamiento de disquinesia y trastornos relacionados.
DK3265429T3 (da) Nanopartikler til anvendelse som hæftningscentre i superledere
TWD174242S (zh) 攜帶型洗淨機
EA201691036A1 (ru) Новое соединение для лечения тяжелой гипогликемии
TWD179337S (zh) 管配件
MX368485B (es) Bioconjugados no aglomerantes de compuestos mimeticos de amilina y polietilenglicol.
CL2016002083A1 (es) Composición antifúngica tópica para el tratamiento de onicomicosis

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM